Journal
Clinical Microbiology and Infection
Publication Date
4-1-2024
Volume
30 Suppl 2
First Page
S1
Last Page
S51
Document Type
Open Access Publication
DOI
10.1016/j.cmi.2024.02.003
Rights and Permissions
Moja L, Zanichelli V, Mertz D, Gandra S, Cappello B, Cooke GS, Chuki P, Harbarth S, Pulcini C, Mendelson M, Tacconelli E, Ombajo LA, Chitatanga R, Zeng M, Imi M, Elias C, Ashorn P, Marata A, Paulin S, Muller A, Aidara-Kane A, Wi TE, Were WM, Tayler E, Figueras A, Da Silva CP, Van Weezenbeek C, Magrini N, Sharland M, Huttner B, Loeb M. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections. Clin Microbiol Infect. 2024 Apr;30 Suppl 2:S1-S51. doi: 10.1016/j.cmi.2024.02.003 © 2024 World Health Organization. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Moja, Lorenzo; Gandra, Sumanth; and et al., "WHO's essential medicines and AWaRe: Recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections." Clinical Microbiology and Infection. 30 Suppl 2, S1 - S51. (2024).
https://digitalcommons.wustl.edu/oa_4/5078
Department
ICTS (Institute of Clinical and Translational Sciences)
